Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

GranuFlo Dialysis Heart Attack

GranuFlo is an acidic concentrate powder used to allow dialysis clinics to mix their own dialysate without storing heavy and expensive containers of liquid solution. It has been sold since 2003 by Fresenius Medical Care for use in thousands of clinics nationwide.

Unfortunately, Granuflo has been linked to dialysis complications that can cause serious heart problems such as Granuflo heart attack. Experts fear hundreds of thousands of patients may have been put at risk.

A heart attack, or myocardial infarction, is the death of heart tissue due to restriction of oxygen-rich blood. This condition affects more than 1 million people in the United States each year.

Heart attacks have been linked to plaque build-up or blood clots in the arteries. However, a Granuflo heart attack can stem from elevated bicarbonate levels in the bloodstream.

Since heart attacks can be fatal, patients are encouraged to seek medical help immediately if they notice any symptoms. These include:

  • Chest pain
  • Dizziness
  • Shortness of breath
  • Coughing
  • Fainting
  • Nausea or vomiting
  • Heart palpitations (fast or irregular heart beats)

In 2010, Fresenius conducted a year-long study which identified the risk of heart problems such as Granuflo heart attacks from improper use of their product. However, instead of informing the public, they concealed the results until March of 2012. Lawyers are helping those affected file claims for their loss.

If you or a loved one suffered a heart attack, cardiopulmonary arrest or death after receiving dialysis, it is important to speak with a lawyer to determine if you qualify for a case. You may be entitled to substantial compensation. Contact us today.

Dialysis is a process by which the blood is cleansed of toxic waste when damaged or failed kidneys can no longer do this naturally. Most dialysate solutions consist primarily of acetic acid. However, Granuflo also contains sodium acetate, which is converted to bicarbonate by the patient’s tissue and liver. 

If Granuflo dialysate is improperly mixed or a doctor prescribes a separate bicarbonate, which is often the case, a patient’s bicarbonate levels can increase. This heightens the risk of cardiopulmonary arrest, metabolic alkalosis or Granuflo dialysis heart attack.

Although Fresenius learned through a study that improper use of their product may contribute to dialysis heart attacks, they only alerted their own doctors. By concealing this risk from the FDA, outside doctors and the public, hundreds of thousands of patients were put at risk of severe heart injury or death.

Many of those affected by heart attack or death of a loved one after dialysis have already filed lawsuits. Due to the number of claims expected, a federal judicial panel has recommended they be combined to a special Multi-District Litigation court. A lawyer can explain whether your case qualifies and how long you have to take action.

Before choosing a lawyer, make sure they are qualified for this type of lawsuit and have experience fighting large drug companies. The DrugRisk Resource Center only recommends law firms that specialize in drug injuries and have handled Granuflo claims.

For more information on the research, warnings, side effects and litigation related to Granuflo, or to speak with a lawyer, contact us today. We are available 24 hours a day to provide help.